This inventor holds 1 USPTO granted patent. Top assignee: Pentraxin Therapeutics Limited. Active years: 2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2012
Title: Innovations of Angus John Morrison in Amyloidosis Treatment
Introduction
Angus John Morrison is a notable inventor based in Glasgow, GB. He has made significant contributions to the field of medicine, particularly in the treatment of amyloidosis. His innovative work has led to the development of a unique compound aimed at stabilizing transthyretin, which is crucial for addressing this complex disease.
Latest Patents
Morrison holds a patent for a compound and its use in the treatment of amyloidosis. The patent details compounds of formula (I) that are designed to stabilize the tetrameric form of transthyretin. This invention is pivotal for the treatment or prevention of amyloidosis, and it includes agents and medicaments that comprise such compounds.
Career Highlights
Angus John Morrison is associated with Pentraxin Therapeutics Limited, where he continues to advance his research and development efforts. His work is characterized by a commitment to improving therapeutic options for patients suffering from amyloidosis.
Collaborations
Morrison has collaborated with notable colleagues in his field, including Steven Victor Ley and Martin Smith. These partnerships have enhanced the scope and impact of his research.
Conclusion
Angus John Morrison's innovative contributions to the treatment of amyloidosis highlight his role as a significant inventor in the medical field. His work not only advances scientific understanding but also offers hope for effective treatments for patients.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile